NCT03408470View on ClinicalTrials.gov

TD-1473 Absorption, Distribution, Metabolism and Excretion (ADME) Study in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 31, 2018

Primary Completion Date

February 21, 2018

Study Completion Date

February 21, 2018

Conditions
Intestinal DisordersBowel Diseases, Inflammatory
Interventions
DRUG

TD-1473 oral capsule

(Intervention description included in arm description)

DRUG

[14C]-TD-1473 IV bolus

(Intervention description included in arm description)

DRUG

[14C]-TD-1473 Oral Capsule

(Intervention description included in arm description)

Trial Locations (1)

68502

Celerion, Lincoln

Sponsors
All Listed Sponsors
lead

Theravance Biopharma

INDUSTRY

NCT03408470 - TD-1473 Absorption, Distribution, Metabolism and Excretion (ADME) Study in Healthy Male Subjects | Biotech Hunter | Biotech Hunter